Achieving Improved Outcomes in Children and Infants with Spinal Muscular Atrophy

Achieving Improved Outcomes in Children and Infants with Spinal Muscular Atrophy is organized by AcademicCME.

Start Date: 11-26-2019
Expires: 11-25-2020

Accreditation:
• AcademicCME designates this live material for a maximum of 1.50 AMA PRA Category 1 CreditsTM.
• AcademicCME designates this live material for a maximum of 1.50 CNE Contact Hours

Description:
This CME/CE activity is derived from content presented at the American Academy of Pediatrics National Conference and Exhibition in New Orleans, LA. The program will outline best practices for achieving improved outcomes in children and infants with spinal muscular atrophy (SMA). The faculty will first delve into the pathophysiology, genetics and diagnostics of SMA, as well as disease progression and potential biomarkers. Recent clinical trial data of both emerged and emerging agents will be reviewed as it relates to clinical decision making for healthcare professionals. Following, the faculty will discuss therapeutic strategies utilizing the interprofessional team, with the goal of improving outcomes and quality of life for SMA patients. This CME/CE symposium will equip the healthcare team with the tools to better treat and manage their patients with spinal muscular atrophy.

Objectives:
• Understand the rapid disease progression of SMA, as well as the role neurofilament as a potential biomarker for predicting motor function in patients
• Analyze the most recent advances in SMA therapeutics
• Utilize the interprofessional healthcare team to develop novel treatment strategies to slow disease progression in infants and children with SMA

Additional details will be posted as soon as information is available